“Lipoprotein(a) as an Unmodifiable Risk Marker in a Modifiable Risk World: Testing, Interpretation and Communication”, JHCS, vol. 2, no. 1, pp. 14–19, Nov. 2021, doi: 10.5281/zenodo.22305492.